- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT04932304
Cognitive Training After Stroke : Effects and Mechanisms
Kognitiv Trening Etter Hjerneslag: Effekter og Mekanismer #2015/1282
Stroke is a major cause of severe cognitive and physical disability. Despite the high and increasing incidence, and large health, economic, social and personal consequences, studies designed to remedy cognitive impairments and improve rehabilitation care following stroke are lacking. A promising line of research have shown that weak electrical current (tDCS) can be a safe, cost-effective, and potent treatment when combined with other rehablitational approaches.
The underlying mechanism is assumed that tDCS facilitates neuronal signaling, improving plasticity and facilitating rehablitational outcome. But further research is needed to better understand the mechanisms at hand, and to better evaluate the potential clinical utility.
The scope for the current project is to investigate both cognitive and neuronal effects of tDCS in combination with cognitive training , with the ultimate goal to improve current rehabilitational healthcare. To achieve this we will use multimodal MRI, EEG, and a comprehensive battery of neuropsychological asessment, to describe and evaluate the effect of tDCS in rehabilitation purposes.
Studienübersicht
Status
Bedingungen
Detaillierte Beschreibung
Participants are randomly assigned to either active or sham condition, using codes provided by the manufacturer and implemented by an in-house Matlab script, pseudo-randomizing participants while maintaining balance in groups of 20. tDCS stimulation is applied at six occasions for each participant, with a minimum of 48 hours between stimulations, aiming at an average of two stimulations per week. Stimulation current is1000 μA, stimulation time was 20 min for the active group with a ramp-up time of 120 s and fade-out time of 30 s. The current intensity is limited to 1 mA to limit the risk of adverse events due to the electrical stimulation. The sham stimulation consists of ramp-up followed by 40 s of active stimulation and then fade-out, following factory settings.
Cognitive training will be done by the computerized working memory training program (Cogmed Systems AB, Stockholm, Sweden) consisting of 25 online training sessions. In this study, to increase feasibility, we utilize 17 sessions over a period of three to four weeks, corresponding to approximately five weekly training sessions. On average, we aim at two training sessions combined with tDCS per week with a minimum of one day between each tDCS session. The remaining CCT sessions are performed at home.
Neuropsychological assessments and MRI assessments are conducted three times: at baseline 1, after a waiting period of 2-4 weeks (baseline 2, before intervention) and immediately post intervention. Self-reported symptoms of fatigue and depression are assessed at five time points, before, during and after completing intervention.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Oslo, Norwegen
- Oslo University Hospital
-
Oslo, Norwegen
- Oslo University Hospital Ullevål
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- MR/CT revealing ischemic or hemorrhagic damage (stroke).
Exclusion Criteria:
- History of illness or damage to the CNS, besides stroke.
- <18 years of age
- Extensive cognitive decline or dementia
- Severe psychiatric disorders
- Substance or alcohol abuse
- Contraindications for MRI.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Verdreifachen
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Aktiver Komparator: Active stimulation
Participants recieving active trancranial direct current stimulation (tDCS) Parameters: 20 minutes anodal tDCS 1mA.
Two times a week, for three weeks.
Anode placed at F3, cathode placed at right cerebellum.
|
|
|
Placebo-Komparator: Sham stimulation
Participants recieving passive / sham trancranial direct current stimulation (tDCS) Two times a week, for three weeks.
Anode placed at F3, cathode placed at right cerebellum.
|
Sham Transcranial direct current stimulation (tDCS)
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Evidence of change in neural activity in attentional-related brain areas after receiving anodal tDCS, as measured with functional MRI
Zeitfenster: One and a half year
|
Change in activation patterns during multiple object tracking (MOT) at first baseline, before initiating training (second baseline, on average 4 weeks after baseline measure), and after a three-week intervention (post-intervention assessment)
|
One and a half year
|
|
Evidence of structural changes after receiving anodal tDCS, as measured with structural MRI
Zeitfenster: One and a half year
|
Structural MRI
|
One and a half year
|
|
Evidence of increased attentional and working memory capacity after receiving anodal tDCS
Zeitfenster: One and a half year
|
Rate of improvement in Cogmed tasks
|
One and a half year
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Evidence of increased attentional capacity after receiving anodal tDCS
Zeitfenster: One and a half year
|
Performance change in The Theory of Visual Attention (TVA) computerized paradigm.
|
One and a half year
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Evidence of change in fatigue severity after receiving tDCS
Zeitfenster: One and a half year
|
Fatigue Severity Scale (FSS), a seven-point Likert scale on subjective fatigue severity/impact.
9 items scored from 1 (less symptoms) to 7 (most severe symptoms).
Scores are reported as mean scores, lowest possible mean = 1, highest possible mean = 7.
|
One and a half year
|
|
Evidence of change in symptoms of depression after receiving tDCS
Zeitfenster: One and a half year
|
Patient Health Questionnaire (PHQ-9), self-reported depressive symptoms.
Scale consists of 9 items, scored from 0 (not at all) to 3 (nearly every day).
Scores are reported as sum scores, range 0 (less symptoms) - 27 (more symptoms)
|
One and a half year
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Studienleiter: Lars T. Westlye, Ph.D, University of Oslo
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 2015/1282
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .